Healthcare & Science Challengers - Presentation by Joerg Land, Managing Director of Tinnitracks at the NOAH 2015 Conference in Berlin, Tempodrom on the 9th of June 2015.
El envío de newsletter es esencial para fidelizar a tus clientes. Tendrás un canal directo con ellos. Aprende a crear plantillas con MailChimp y aprovecha para ofrecerle a tus clientes contenido de valor. Cuando publicas periódicamente contenido de alta calidad, útil y de relevancia, conseguirás que un alto porcentaje de usuarios abra los emails. Y este interés puede terminar en una visita a tu centro de estética. :)
El envío de newsletter es esencial para fidelizar a tus clientes. Tendrás un canal directo con ellos. Aprende a crear plantillas con MailChimp y aprovecha para ofrecerle a tus clientes contenido de valor. Cuando publicas periódicamente contenido de alta calidad, útil y de relevancia, conseguirás que un alto porcentaje de usuarios abra los emails. Y este interés puede terminar en una visita a tu centro de estética. :)
Este documento es un cheatsheet sobre las herramientas que ofrece el software de codigo abierto Freemat muy similar a Matlab. El cual atraves de imagenes se describen muestran imagenes de los graficos y la gran mayoria de los guiones de las aplicaciones matematicas.
Presentation on the City and Regional Archives of Vienna held by Brigitte Rigele (Director of the City and Regional Archives of Vienna) at the symposium "Genealogische Quellen - Genealogie als Quelle" on 15.01.2015 in St. Pölten (AT).
Consumer Goods, Retail & Ecommerce - Presentation by Sascha Mallah, CEO of Teufel at the NOAH Conference Berlin 2017, Tempodrom on the 22nd of June 2017.
Music and video streaming services such as Spotify, Deezer, Netflix, YouTube, or Amazon Instant Video account for a continuously increasing part of media consumption in Germany. Although traditional media formats, such as linear TV, CDs and DVDs, have been written off repeatedly, many consumers could not live without them.
Which changes in media usage patterns are actually observable? Why are consumers attracted to streaming services? Why do some consumers still prefer traditional media formats? What are the implications for telecommunications operators?
Finding answers to these questions is the objective of this study. The responses we present are surprising and should encourage decision-makers both at content and telecommunications providers to reflect upon their respective business strategies.
In order to address all aspects of these issues from a consumer behaviour perspective, this study used a mixed-methods approach combining quantitative and qualitative research methods. The first step involved a survey of a representative sample of more than 1,000 German consumers. The results of this survey were then reflected on and scrutinised in 28 in-depth interviews with consumers.
Startup Stage - MedTech - Presentation by Chris McCann, Co-Founder & CEO of Snap 40 at the NOAH Conference London 2016, Old Billingsgate on the 11th of November 2016.
The technical challenge and the death of music radio?
Is there a specific and intrinsic value to radio content? Or is it all a question of distribution, access points and technology?
There are trends that suggest we could be moving towards the death of music radio, but is the alternative technically feasible yet? Let's not forget that TV was going see off radio back in the fifties and it is still here.
Este documento es un cheatsheet sobre las herramientas que ofrece el software de codigo abierto Freemat muy similar a Matlab. El cual atraves de imagenes se describen muestran imagenes de los graficos y la gran mayoria de los guiones de las aplicaciones matematicas.
Presentation on the City and Regional Archives of Vienna held by Brigitte Rigele (Director of the City and Regional Archives of Vienna) at the symposium "Genealogische Quellen - Genealogie als Quelle" on 15.01.2015 in St. Pölten (AT).
Consumer Goods, Retail & Ecommerce - Presentation by Sascha Mallah, CEO of Teufel at the NOAH Conference Berlin 2017, Tempodrom on the 22nd of June 2017.
Music and video streaming services such as Spotify, Deezer, Netflix, YouTube, or Amazon Instant Video account for a continuously increasing part of media consumption in Germany. Although traditional media formats, such as linear TV, CDs and DVDs, have been written off repeatedly, many consumers could not live without them.
Which changes in media usage patterns are actually observable? Why are consumers attracted to streaming services? Why do some consumers still prefer traditional media formats? What are the implications for telecommunications operators?
Finding answers to these questions is the objective of this study. The responses we present are surprising and should encourage decision-makers both at content and telecommunications providers to reflect upon their respective business strategies.
In order to address all aspects of these issues from a consumer behaviour perspective, this study used a mixed-methods approach combining quantitative and qualitative research methods. The first step involved a survey of a representative sample of more than 1,000 German consumers. The results of this survey were then reflected on and scrutinised in 28 in-depth interviews with consumers.
Startup Stage - MedTech - Presentation by Chris McCann, Co-Founder & CEO of Snap 40 at the NOAH Conference London 2016, Old Billingsgate on the 11th of November 2016.
The technical challenge and the death of music radio?
Is there a specific and intrinsic value to radio content? Or is it all a question of distribution, access points and technology?
There are trends that suggest we could be moving towards the death of music radio, but is the alternative technically feasible yet? Let's not forget that TV was going see off radio back in the fifties and it is still here.
For your eyes and ears - streaming services in GermanyRené C.G. Arnold
Music and video streaming services have increasing their user numbers in Germany continuously over the past years. Spotify, Netflix and Amazon Video have made their way into Germany’s living rooms, smartphones, tablets and computers. The digital libraries of public broadcasters have been similarly successful. Just like the two preceding studies by WIK and Fresenius University of Applied Sciences, the present one explores the apparent changes in the way that consumers in Germany enjoy music and audio-visual content.
Next to the focus on audio-visual media usage patterns, the study addresses two current themes. First, we examine the impact that the growing popularity of streaming services has had on the sales of devices. Specifically, we show if and how new demand for devices like headphones and smart TV sets emerges. Second, the study explores augmented and virtual reality formats as completely new ways of enjoying audio-visual content. We try and find out whether these formats may be heading for the mass market as it has often been stipulated before.
For the present study, we conducted a representative survey of 2,036 consumers in Germany. To interpret these results, we added 20 semi-structured individual interviews with consumers.
Champion Home Automation - Keynote by Christian Arnold, Managing Director of enera at the NOAH 2015 Conference in Berlin, Tempodrom on the 9th of June 2015.
Corporate Entrepreneurship and Corporate Venturing Activities in PhilipsBonny Fu
We discuss on one of the major health and electronics companies in the world –Philips. We analyzed the corporate entrepreneurship and venture activities within Philips’ transformation in its century-year-old development. Philips started off as lighting company and transformed into one of the main healthcare company globally and continued to innovate in this current Internet of things era.
Digital Health: Company presentation by Giorgio Koppehele, CEO & Co-founder of Magic Horizons, at the NOAH Conference London 2019, 30-31 October, Old Billingsgate.
How many people are affected by hearing loss? What impact does hearing loss have on my health? And what are the social consequences of hearing loss? You can find answers to these and other questions here.
Structuring the "Fuzzy Front End of Innovation“ – From Strategic Foresight to...Kai Numssen
Structuring the "Fuzzy Front End of Innovation“ –
From Strategic Foresight to Implementable Technology and Product Innovations
Front End of Innovation EMEA, Feb. 4th, 2014 - Munich (FEI EMEA 2014)
Abstract:
In order to meet the increasing pressure to innovate driven by accelerated change in technologies and markets and by intensifying global competition, leading-edge companies need a systematic Strategic Foresight, by which emerging threats as well as future opportunities and potentials are anticipated at an early stage. Besides, an innovation management must be able to transform the detected needs and opportunities to innovate into implementable concepts for technology and product innovations, which includes the ability to handle the fuzzy input in the innovation process.
SPINNER, a worldwide leading company in passive radiofrequency technology, has developed a consistent proceeding, which bridges the gap from fuzzy future factors and strategic requirements to technology and product innovations. The presentation shows how SPINNER’s innovation management spots and evaluates future market demands as well as emerging enabling technologies, how innovation impulses are derived, and how innovation ideas are generated. It also addresses the involved methods and tools and explains how SPINNER’s Innovation Idea Evaluation System INES paves the way from fuzzy ideas to implementable concepts, prioritizing the most valuable ideas and allowing for dynamic steering under fluctuating conditions.
Speaker:
Dr. Kai Numssen – Head of Innovation Management, SPINNER GmbH, Munich / Westerham, Germany
Official speaker book for the NOAH 2019 Conference in Tel Aviv with comprehensive background information on all presenting speakers and their companies.
Official speaker book for the NOAH 2018 Conference in Tel Aviv with comprehensive background information on all presenting speakers and their companies.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Tinnitracks - NOAH15 Berlin
1. Confidential – do notdistribute Sonormed GmbH2015
Sonormed – Digital Audiology
2. SAVE THE DATE
GET YOUR TICKET NOW!
www.noah-conference.com/request-invitation
Old Billingsgate, London Tempodrom, Berlin
12-13 NOV2015 8 - 9 JUN2016
3. Confidential – do notdistribute Sonormed GmbH2015
Audiology: Billion Dollar Hearing Market
17%
Compensated
Oligopolisitc structure
High margins
1/5Population
4. Confidential – do notdistribute Sonormed GmbH2015
> Grow the pie and reallocate the slices
Emerging markets
Older and more tech
saavy
Unmet
demand
Enabling consumer
electronics
Trends in Audiology
Demographics Consumer Electronics
5. Confidential – do notdistribute Sonormed GmbH2015
Chronic desease
25+ Mil. Patients in Europe
Current solutions lack effect or compliance
Tinnitus
Applying scientific knowledge
Audiology: Billion Dollar Hearing Market
7. Confidential – do notdistribute Sonormed GmbH2015
Tinnitracks: The Innovative Tinnitus Therapy
Relieable
Effective
Personalized
hardware based
therapies
Long local
treatments
Expensive
therapies
8. Confidential – do notdistribute Sonormed GmbH2015
Pushing the technology even further
Most tinnitus patients have hearing loss
1.
Digital Hearing Aid
Expensive frequency matching
hardware
2.
Tinnitracks Audiometry
9. Confidential – do notdistribute Sonormed GmbH2015
Matthias Lanz
CTO
Investors
Industry Angels
Heiko Hubertz (Bigpoint founder)
High-Tech Gründerfonds
Innovationsstarter
Quotas (family office)
Adrian Nötzel
Head of R&D
Jörg Land
CEO - BizDev/Marketing
Sonormed Team
Markets
Germany
Austria
Netherlands
The team has the background, the momentum and the vision to suceed
10. Confidential – do notdistribute Sonormed GmbH2015
• Subscription model
• €19/month
• Channels:
• Tinnitracks.com
• App-Store
• Local audiologists
(in cooperation with Sennheiser)
• Partners
The business model
11. Confidential – do notdistribute Sonormed GmbH2015
Classified Medical Device
Strong industry partner
Network of local audiologists
Audiology infrastructure
Distribution partner
Strong IT-Audio-Health team
A highly fertile ground for more hearing technologies!
The audiology infrastructure